Jason Tardio Ovid Therapeutics Inc. (OVID) insider trading activity

OVID Quotes by TradingView

Jason Tardio is Chief Operating Officer of Ovid Therapeutics Inc.. Currently has a direct ownership of 28,125 shares of OVID, which is worth approximately $28,968. The most recent transaction as insider was on Feb 22, 2024, when has been sold 28,125 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 28.1K
0% 3M change
Infinity% 12M change
Total Value Held $28,968

Jason Tardio Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 22 2024
BUY
Grant, award, or other acquisition
-
28,125 Added 50.0%
28,125 Common Stock
Sep 12 2022
SELL
Open market or private sale
$37,290 $2.15 p/Share
17,344 Reduced 100.0%
0 Common Stock

Also insider at

IMUX
IMMUNIC, INC. Healthcare
President and COO
JT

Jason Tardio

Chief Operating Officer
New York, NY

Track Institutional and Insider Activities on OVID

Follow Ovid Therapeutics Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OVID shares.

Notify only if

Insider Trading

Get notified when an Ovid Therapeutics Inc. insider buys or sells OVID shares.

Notify only if

News

Receive news related to Ovid Therapeutics Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on OVID